rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors.

In comparison to MC38 models, the difference in tumor growth rate between double and triple combination in the CT26 tumor model did not reach statistical significance( figure 7D,E ).

also in 111,027 other papers